FZ-A038
FZ-A038 is a delta-like ligand 3 (DLL3) targeted, humanized monoclonal antibody. FZ-A038 can be used for synthesis of DLL3 targeting ADC FZ-AD005 (HY-164729) [1].
Product Specifications
UNSPSC
12352203
Target
ADC Antibody
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/fz-a038.html
Purity
99.22
Smiles
[FZ-A038]
Molecular Weight
(145 kDa)
References & Citations
[1]Guo Q, et al., FZ-AD005, a Novel DLL3-Targeted Antibody-Drug Conjugate with Topoisomerase I Inhibitor, Shows Potent Antitumor Activity in Preclinical Models. Mol Cancer Ther. 2024 Oct 1;23 (10) :1367-1377. |[2]Guo Q, et al., FZ-AD005, a Novel DLL3-Targeted Antibody-Drug Conjugate with Topoisomerase I Inhibitor, Shows Potent Antitumor Activity in Preclinical Models. Mol Cancer Ther. 2024 Oct 1;23 (10) :1367-1377.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
354833-01 48 Tests
Cleaved BID/TBID (Cleaved BH3-interacting domain death agonist) BioAssayTM ELISA Kit (Human) discontinued
Ask
View Details 
354833-02 96 Tests
Cleaved BID/TBID (Cleaved BH3-interacting domain death agonist) BioAssayTM ELISA Kit (Human) discontinued
Ask
View Details 
GTR15337820 1 Vial
Lentiviral human BASP1 shRNA (UAS) - Lentiviral human BASP1 shRNA (UAS) (25)
Ask
View Details